Literature DB >> 26815367

Influence of MX1 promoter rs2071430 G/T polymorphism on susceptibility to systemic lupus erythematosus.

Suad AlFadhli1, Mashael Al-Mutairi2, Bader Al Tameemi2, Rasheeba Nizam2.   

Abstract

The expression of interferon inducible genes are reported to be heightened in systemic lupus erythematosus (SLE); nevertheless, not much is known regarding the genetic variants underlying these genes and their role in the pathogenesis of disease. Herein, we aim to explore the potential association and contribution of polymorphisms in MX1 gene (i) promoter with part of exon 1 (ii) intron 6, and (iii) their resulting haplotypes, with susceptibility to SLE. A total of 306 subjects, 152 SLE and 154 healthy controls (HC), were screened by direct sequencing method. Statistical analysis was carried out using appropriate software. The screening region of interest in MX1 revealed the existence of promoter (-123C/A, -88G/T, -20 A/C) and intron 6 (+9862G/A, +10190G/A, +9901C/G, +9920C/A, +9959C/T, +10047A/G) variants in SLE and HC. A significant association was observed between MX1 -88G/T SNP and susceptibility to SLE (χ (2) = 4.18, p = 0.04, OR = 1.89, 95 % CI 1.03-3.5). Haplotype analysis also revealed increased risk of SLE among individuals carrying CTA haplotype (-123 C, -88 T, -20 A) (χ (2) = 5.74, p = 0.017, OR = 4.28, 95 % CI 1.30-14.06). None of the other tested variants showed any significant association with SLE. The present study is the first to reveal the influence of genetic variation in MX1 gene in susceptibility to SLE.

Entities:  

Keywords:  Lupus; MX1 gene; Susceptibility

Mesh:

Substances:

Year:  2016        PMID: 26815367     DOI: 10.1007/s10067-016-3179-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice.

Authors:  Déborah Braun; Pedro Geraldes; Jocelyne Demengeot
Journal:  J Autoimmun       Date:  2003-02       Impact factor: 7.094

2.  Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Authors:  Xuebing Feng; Hui Wu; Jennifer M Grossman; Punchong Hanvivadhanakul; John D FitzGerald; Grace S Park; Xin Dong; Weiling Chen; Michelle H Kim; Haoling H Weng; Daniel E Furst; Alan Gorn; Maureen McMahon; Mihaela Taylor; Ernest Brahn; Bevra H Hahn; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2006-09

3.  Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen.

Authors:  D E Speiser; T Zürcher; H Ramseier; H Hengartner; P Staeheli; O Haller; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.

Authors:  A A Bengtsson; G Sturfelt; L Truedsson; J Blomberg; G Alm; H Vallin; L Rönnblom
Journal:  Lupus       Date:  2000       Impact factor: 2.911

5.  Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients.

Authors:  Patrick Coit; Matlock Jeffries; Nezam Altorok; Mikhail G Dozmorov; Kristi A Koelsch; Jonathan D Wren; Joan T Merrill; W Joseph McCune; Amr H Sawalha
Journal:  J Autoimmun       Date:  2013-04-24       Impact factor: 7.094

6.  Cancers and immune related diseases associated with Down's syndrome: a record linkage study.

Authors:  M J Goldacre; C J Wotton; V Seagroatt; D Yeates
Journal:  Arch Dis Child       Date:  2004-11       Impact factor: 3.791

7.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

8.  Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon.

Authors:  K M Kälkner; L Rönnblom; A K Karlsson Parra; M Bengtsson; Y Olsson; K Oberg
Journal:  QJM       Date:  1998-06

9.  Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Authors:  Lynda Bennett; A Karolina Palucka; Edsel Arce; Victoria Cantrell; Josef Borvak; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

Review 10.  Microarray analysis of gene expression in lupus.

Authors:  Mary K Crow; Jay Wohlgemuth
Journal:  Arthritis Res Ther       Date:  2003-10-13       Impact factor: 5.156

View more
  2 in total

1.  The Immunogenetics of Alopecia areata.

Authors:  Fateme Rajabi; Fahimeh Abdollahimajd; Navid Jabalameli; Mansour Nassiri Kashani; Alireza Firooz
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Bioinformatics analysis of epigenetic and SNP-related molecular markers in systemic lupus erythematosus.

Authors:  Shuoshan Xie; Qinghua Zeng; Shaxi Ouyang; Yumei Liang; Changjuan Xiao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.